BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 33737108)

  • 1. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment.
    Boyd LNC; Andini KD; Peters GJ; Kazemier G; Giovannetti E
    Semin Cancer Biol; 2022 Jul; 82():184-196. PubMed ID: 33737108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
    J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts.
    Pfeifer E; Burchell JM; Dazzi F; Sarker D; Beatson R
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma.
    Sperb N; Tsesmelis M; Wirth T
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblasts in pancreatic cancer: molecular and clinical perspectives.
    Rebelo R; Xavier CPR; Giovannetti E; Vasconcelos MH
    Trends Mol Med; 2023 Jun; 29(6):439-453. PubMed ID: 37100646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting.
    Vaish U; Jain T; Are AC; Dudeja V
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology.
    Feldmann K; Maurer C; Peschke K; Teller S; Schuck K; Steiger K; Engleitner T; Öllinger R; Nomura A; Wirges N; Papargyriou A; Jahan Sarker RS; Ranjan RA; Dantes Z; Weichert W; Rustgi AK; Schmid RM; Rad R; Schneider G; Saur D; Reichert M
    Gastroenterology; 2021 Jan; 160(1):346-361.e24. PubMed ID: 33007300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
    Huang H; Brekken RA
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
    Yu Y; Schuck K; Friess H; Kong B
    Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities.
    Qin Q; Yu R; Eriksson JE; Tsai HI; Zhu H
    Cancer Lett; 2024 Jun; 591():216859. PubMed ID: 38615928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer.
    Pereira BA; Vennin C; Papanicolaou M; Chambers CR; Herrmann D; Morton JP; Cox TR; Timpson P
    Trends Cancer; 2019 Nov; 5(11):724-741. PubMed ID: 31735290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
    Liu H; Shi Y; Qian F
    Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
    Awaji M; Saxena S; Wu L; Prajapati DR; Purohit A; Varney ML; Kumar S; Rachagani S; Ly QP; Jain M; Batra SK; Singh RK
    FASEB J; 2020 Jul; 34(7):9405-9418. PubMed ID: 32453916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
    Neuzillet C; Nicolle R; Raffenne J; Tijeras-Raballand A; Brunel A; Astorgues-Xerri L; Vacher S; Arbateraz F; Fanjul M; Hilmi M; Samain R; Klein C; Perraud A; Rebours V; Mathonnet M; Bièche I; Kocher H; Cros J; Bousquet C
    J Pathol; 2022 Dec; 258(4):408-425. PubMed ID: 36102377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer.
    Stouten I; van Montfoort N; Hawinkels LJAC
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palladin isoforms 3 and 4 regulate cancer-associated fibroblast pro-tumor functions in pancreatic ductal adenocarcinoma.
    Alexander JI; Vendramini-Costa DB; Francescone R; Luong T; Franco-Barraza J; Shah N; Gardiner JC; Nicolas E; Raghavan KS; Cukierman E
    Sci Rep; 2021 Feb; 11(1):3802. PubMed ID: 33589694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition.
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA;
    Cancer Res; 2021 Jul; 81(13):3461-3479. PubMed ID: 33980655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer.
    Niu N; Shen X; Wang Z; Chen Y; Weng Y; Yu F; Tang Y; Lu P; Liu M; Wang L; Sun Y; Yang M; Shen B; Jin J; Lu Z; Jiang K; Shi Y; Xue J
    Cancer Cell; 2024 May; 42(5):869-884.e9. PubMed ID: 38579725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
    Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
    EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose-derived mesenchymal stem cells differentiate into pancreatic cancer-associated fibroblasts in vitro.
    Miyazaki Y; Oda T; Mori N; Kida YS
    FEBS Open Bio; 2020 Nov; 10(11):2268-2281. PubMed ID: 32931156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.